Shi Q. A Padua moment for factor VIII gene therapy. Blood. 2026 Jan 22;147(4):322-323 PMID: 41569621 SCOPUS ID: 2-s2.0-105028227649 01/22/2026
Yu H, Schroeder JA, Mattson JG, Gao C, Shi Q. Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice. Blood Adv. 2026 Jan 13 PMID: 41529228 01/13/2026
Jing W, Schroeder JA, Kumar S, Chen J, Cai Y, Malec LM, Dent AL, Cui W, Shi Q. The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice. Blood. 2025 Aug 21;146(8):998-1010 PMID: 40493881 PMCID: PMC12412428 SCOPUS ID: 2-s2.0-105009644239 06/10/2025
Kaminski TW, Zhang H, Katoch O, Shi Q, Kato GJ, Sundd P, Pradhan-Sundd T. Small-molecule inhibitor screen to identify mechanisms of sickle hemoglobin clearance by liver endothelium. Blood Vessel Thromb Hemost. 2025 May;2(2) PMID: 40487985 PMCID: PMC12143466 06/09/2025
Shi Q, Mattson JG, Morateck PA, Christopherson PA, Schroeder JA, Fahs SA, Rapten J, Schulte ML, Weiler H, Zhu J, Haberichter SL, Flood VH, Montgomery RR. The pivotal role of von Willebrand factor binding to platelet αIIbβ3 in stabilizing the formation of a platelet plug at sites of injury. Haematologica. 2025 Oct 01;110(10):2343-2355 PMID: 40400463 PMCID: PMC12485351 SCOPUS ID: 2-s2.0-105017783600 05/22/2025
Eapen M, Malec LM, Armant MA, Johnson BD, Shi Q, Xu H, Du LM, Jerkins JH, Duffy LJ, Bushman FD, Lee C, Petrichenko A, Hematti P, Brazauskas R, Jobe SM, Hari PN, Wilcox DA. Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History. N Engl J Med. 2025 Jan 23;392(4):412-414 PMID: 39842018 PMCID: PMC11756741 SCOPUS ID: 2-s2.0-85216608254 01/22/2025
Luo L, An X, Wang Y, Zheng Q, Lin K, Shi Q, Chen Y. Chemokine CXCL13 facilitates anti-FVIII inhibitory antibody development in hemophilia A patients and murine models. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113472 PMID: 39471695 PMCID: PMC12117665 SCOPUS ID: 2-s2.0-85207599955 10/30/2024
Chen Z, Zheng Q, Wang Y, An X, Yirga SK, Lin D, Shi Q, Huang M, Chen Y. CXCL13/CXCR5 axis facilitates TFH expansion and correlates with disease severity in adults with immune thrombocytopenia. Thromb Res. 2024 Dec;244:109196 PMID: 39454362 SCOPUS ID: 2-s2.0-85207009382 10/26/2024
Chen Y, Li J, Schroeder JA, Jing W, Shi Q. Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors. J Thromb Haemost. 2024 Nov;22(11):3035-3047 PMID: 39127324 PMCID: PMC11513242 SCOPUS ID: 2-s2.0-85202518466 08/11/2024
Zheng Q, Lin K, Zhang N, Shi Q, Wu Y, Chen Y. Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A mice. Int Immunopharmacol. 2024 Sep 30;139:112735 PMID: 39067397 07/28/2024